Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy

PURPOSE: Although neoadjuvant chemotherapy is associated with a survival advantage in pure urothelial, muscle invasive bladder cancer, the role of neoadjuvant chemotherapy is less clear in variant histology or urothelial carcinoma with divergent differentiation. We compared chemotherapy response and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Urol
Auteurs principaux: Hajiran, Ali, Azizi, Mounsif, Aydin, Ahmet M., Zemp, Logan, Peyton, Charles C., Dhillon, Jasreman, Nealon, Samantha, Reich, Richard R., Cao, Biwei, Li, Roger, Manley, Brandon J., Sexton, Wade J., Gilbert, Scott M.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864376/
https://ncbi.nlm.nih.gov/pubmed/32783489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001325
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires